Value of Apoptotic, Antiapoptotic, and Cell Proliferation Markers in the Treatment of Graves’ Disease

International Journal of Endocrinology - United States
doi 10.1155/2018/3171280
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Comparison of the Value of PCNA and Ki-67 as Markers of Cell Proliferation in Ameloblastic Tumors

Medicina Oral, Patologia Oral y Cirugia Bucal
MedicineOtorhinolaryngologySurgeryDentistry
2013English

Treatment of Adult Graves’ Disease

Annales d'Endocrinologie
MedicineEndocrinologyMetabolismDiabetes
2018English

Surgical Treatment of Graves Disease

Archives of Head and Neck Surgery
2018English

Proliferation Markers in Tumours: Interpretation and Clinical Value

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1998English

The Evolving Role of Selenium in the Treatment of Graves' Disease and Ophthalmopathy

Journal of Thyroid Research
EndocrinologyMetabolismDiabetes
2012English

Immunoexpression of Cell Proliferation Markers in Oral Squamous Cell Carcinoma

International journal of odontostomatology
2016English

Melanoma-Associated Cancer-Testis Antigen 16 (CT16) Regulates the Expression of Apoptotic and Antiapoptotic Genes and Promotes Cell Survival

PLoS ONE
Multidisciplinary
2012English

Prognostic Value of Lymphoma-Specific S-Phase Fraction Compared With That of Other Cell Proliferation Markers

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1999English

Editorial: Apoptotic Cell Clearance in Health and Disease

Frontiers in Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy